Add-On Reslizumab Lowers Asthma Exacerbation Rates in Aspirin-Sensitive Patients
Reslizumab appears to improve clinical asthma exacerbation rates among patients with Aspirin Exacerbated Respiratory Disease (AERD)
AAAAI 2017
Prasugrel: A Potential Treatment for AERD?
Study data from a randomized, double-blind, placebo-controlled trial of prasugrel for the treatment of AERD presented at the 2017 AAAAI Annual Meeting.
